Home > Boards > US Listed > Biotechs > Minerva Neurosciences, Inc. (NERV)

Exactly! Big pharma can make $billions from this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 510
Posts 34,595
Boards Moderated 5
Alias Born 12/12/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2019 4:27:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:56:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/13/2019 4:29:21 PM
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/12/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2019 6:10:39 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:45:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:44:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:43:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:42:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:41:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/31/2019 5:40:33 PM
Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019 GlobeNewswire Inc. - 5/29/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2019 4:12:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/16/2019 6:10:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 8:39:48 AM
Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment ... GlobeNewswire Inc. - 5/13/2019 8:15:00 AM
Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates GlobeNewswire Inc. - 5/6/2019 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2019 7:02:44 AM
Minerva Neurosciences to Report First Quarter 2019 Financial Results and Business Updates on May 6, 2019 GlobeNewswire Inc. - 4/29/2019 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/17/2019 7:04:17 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/17/2019 7:01:46 AM
Withdrawal of Registration Statement (rw) Edgar (US Regulatory) - 4/11/2019 4:20:34 PM
Minerva Neurosciences Presents Pre-Clinical Data Suggesting a Mechanistic Role of Roluperidone in Addressing Negative Symptom... GlobeNewswire Inc. - 4/11/2019 8:30:00 AM
Minerva Neurosciences to Host Webcast Event on Schizophrenia GlobeNewswire Inc. - 3/18/2019 8:30:00 AM
Minerva Neurosciences Reports Fiscal 2018 Fourth Quarter and Year End Financial Results and Business Updates GlobeNewswire Inc. - 3/12/2019 7:30:00 AM
crudeoil24 Member Level  Thursday, 05/26/16 10:37:50 PM
Re: otcmoneydoubler post# 64
Post # of 113 
Exactly! Big pharma can make $billions from this med once phase III and market approvals by FDA as well as by other countries around the world.
We may get a day of consolidation, but I think it will be off and running again next week. About a dozen tutes added shares earlier this month.
More tutes will want in NERV now. + hedge funds, pension plans, and university endowment funds.
After today's action float may even be below 10M shares now.
Maybe Baker Bros bought in today. Expect to see a 13-G some form 3'and 4's.
NERV may be going a lot higher even before FDA phase III approval.

I have link on tutes ownership in an earlier post.

DUKE BASKETBALL and NOTRE DAME FOOTBALL
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist